- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
NAFLD tied to brain damage in patients with type 2 diabetes without cognitive impairment: Study
China: A recent study has suggested that controlling lipid levels, blood glucose levels, and abdominal obesity may reduce brain damage in patients with type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).
The findings, published in Diabetes, Obesity and Metabolism, provide novel insights into neuroimaging correlates for underlying pathophysiological processes inducing brain damage in patients with type 2 diabetes (T2D) with NAFLD.
T2D and NAFLD are the two most prevalent metabolic dysfunction types and have overlapping pathophysiological aspects. There is an increasing incidence of both conditions, posing severe health threats. About 55.5% of type 2 diabetes patients have NAFLD.
Cognitive impairment is a recognizable and clinically significant complication of T2D; however, recently, the neurocognitive implications of NAFLD have garnered significant attention. T2D patients are at 1.5 to 2.5 times higher risk of developing dementia than those without diabetes. NAFLD has been associated with cerebral perfusion, cognitive dysfunction, and brain ageing. However, there is no clarity on whether NAFLD worsens brain damage in T2D patients.
Bing Zhang, Nanjing University, Nanjing, China, and colleagues aimed to investigate the neural static and dynamic intrinsic activity of intra-/inter-network topology among patients with type 2 diabetes with NAFLD and those without NAFLD (T2NAFLD group and T2noNAFLD group, respectively) and to evaluate the relationship with metabolism.
The study included fifty-six patients with T2NAFLD, 78 with T2noNAFLD, and 55 healthy controls (HCs). Participants had normal cognition and underwent clinical measurements, functional magnetic resonance imaging (MRI) scans, and local cognition evaluation. Static functional network connectivity, frequency spectrum parameters, and temporal properties of dynamic functional network connectivity were identified using independent component analysis.
The study led to the following findings:
- T2NAFLD patients had more disordered glucose and lipid metabolism, had more severe insulin resistance, and were more obese than T2noNAFLD patients
- Type 2 diabetes patients exhibited disrupted brain function, as evidenced by alterations in intra-/inter-network topology, even without clinically measurable cognitive impairment.
- T2NAFLD patients had more significant reductions in the frequency spectrum parameters of cognitive executive and visual networks than those with T2noNAFLD.
- Altered brain function in T2D patients was correlated with postprandial glucose, high-density lipoprotein cholesterol, and waist-hip ratio.
"Our study indicates the presence of brain function disruption before the clinically measurable cognitive in T2D patients, and T2NAFLD worsens intra-network rather than inter-network disruption," the researchers wrote. "Therefore, the impact of T2NAFLD is less extensive for cognitively normal T2D patients.
"Brain alterations were related to dysregulated lipid metabolism, hyperglycaemia, and waist-hip ratio (WHR); therefore, controlling lipid and blood glucose levels and abdominal obesity may potentially reduce the brain damage in these patients," they concluded.
Reference:
Li, Xin, et al. "Non-alcoholic Fatty Liver Disease Is Associated With Brain Function Disruption in Type 2 Diabetes Patients Without Cognitive Impairment." Diabetes, Obesity & Metabolism, 2023.
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751